Latest Fibrin Stories

2010-04-20 12:05:31

Scientists from the University of Granada, Spain, have generated artificial human skin by tissular engineering basing on agarose-fibrin biomaterial. The artificial skin was grafted onto mice, and optimal development, maturation and functionality results were obtained. This pioneering finding will allow the clinical use of human skin and its use in many laboratory tests on biological tissues "“ which, additionally, would avoid the use of laboratory animals. Further, this finding could be...

2010-04-19 15:47:22

OHSU researchers say Gamma-prime fibrinogen test may be used in conjunction with cholesterol test to better predict who is most likely to suffer from a heart attack A simple blood test can identify people who are at risk for a heart attack, including thousands who don't have high cholesterol, according to researchers at Oregon Health & Science University. The new test measures gamma-prime fibrinogen, a component of the blood's clotting mechanism. Elevated levels indicate greater...

2010-04-05 11:39:00

Blood-clotting patch is absorbed by the body SILVER SPRING, Md., April 5 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) TachoSil is a ready-to-use surgical patch composed of a dry...

2010-03-11 01:00:00

LEIDEN, The Netherlands and SEATTLE, Washington, March 11, 2010 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery...

2010-01-07 01:00:00

LEIDEN, The Netherlands and SEATTLE, Washington, January 7 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM). The loan consists of an...

2009-12-22 13:43:03

Fibrin sealant has been an extremely effective and widely used adjunct to surgical procedures to control diffuse slow bleeding over large surfaces. In addition, fibrin sealant has been used as a carrier for other compounds. Thus, it has been used to release medicines slowly at a fixed site and is therefore effective for a long time. A study led by Jian-Zhu Fu from the Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, has recently been published on December...

2009-11-24 15:31:35

Cell fragments called platelets are essential to promote blood clotting. Virginia Tech faculty members and students have discovered novel molecular interactions at the surface of platelets that control blood clotting. The Virginia Tech researchers describe how platelets perform this life-saving magic in the November 24 (8 p.m. Eastern U.S. Time) online issue of the journal PLoS ONE (Public Library of Science) in the article "Sulfatides Partition Disabled-2 in Response to Platelet Activation,"...

2009-09-14 11:29:00

HAE:TSX MONTREAL, Sept. 14 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) reported today on current activities and released the financial results of its third quarter ended July 31. Current Activities Haemacure and Angiotech Pharmaceuticals, Inc. started work pursuant to the strategic collaboration entered into in June 2009, including the shipment of product to Angiotech. This collaboration provides Angiotech with license, distribution and supply rights for Haemacure's...

2009-09-08 15:45:00

HAE: TSX MONTREAL, Sept. 8 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company, announces that its Chairman and CEO, Mr. Joseph Galli, will present at the Rodman Renshaw 11th Annual Healthcare Conference on September 9, 2009 at 2:00 p.m. at the New York Palace Hotel in New York. The presentation will be live by webcast at http://www.wsw.com/webcast/rrshq15/hae.to. Please visit the site at least five minutes prior to start time for instructions....

2009-08-06 14:45:00

Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers -- a blood clot -- that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'